Global Hematological Cancers Market Will Exceed $70 Billion by 2022; Finds New Report
The market for hematological cancers, which covers leukemia, lymphoma and myeloma, is expected to more than double from $30.7 billion in 2015 to $70.1 billion by 2022, representing a compound annual growth rate of 12.5%, according to new report.
View full press release